CATALOGO DEI PRODOTTI DELLA RICERCA

AMBROSETTI, Achille
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.042
EU - Europa 10.117
AS - Asia 6.808
SA - Sud America 881
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 195
OC - Oceania 49
AN - Antartide 1
Totale 31.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.661
RU - Federazione Russa 2.998
SG - Singapore 2.703
GB - Regno Unito 2.669
CN - Cina 2.135
IT - Italia 1.144
DE - Germania 777
BR - Brasile 704
SE - Svezia 615
VN - Vietnam 546
FR - Francia 537
HK - Hong Kong 482
FI - Finlandia 442
IE - Irlanda 415
KR - Corea 200
UA - Ucraina 173
CA - Canada 169
BD - Bangladesh 148
IN - India 123
TR - Turchia 79
AR - Argentina 69
ID - Indonesia 58
JP - Giappone 51
NL - Olanda 50
AU - Australia 48
MX - Messico 46
PL - Polonia 44
NG - Nigeria 43
BE - Belgio 41
ES - Italia 39
ZA - Sudafrica 36
IR - Iran 32
IQ - Iraq 31
IL - Israele 30
CR - Costa Rica 29
EC - Ecuador 28
PK - Pakistan 27
SV - El Salvador 27
CZ - Repubblica Ceca 26
AT - Austria 21
CO - Colombia 21
SA - Arabia Saudita 21
VE - Venezuela 20
GT - Guatemala 18
UZ - Uzbekistan 17
EG - Egitto 16
HN - Honduras 16
RO - Romania 16
MA - Marocco 15
GR - Grecia 14
JM - Giamaica 14
SC - Seychelles 14
CL - Cile 12
DZ - Algeria 12
MY - Malesia 12
NI - Nicaragua 12
NP - Nepal 12
LT - Lituania 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
PH - Filippine 10
PY - Paraguay 10
TN - Tunisia 10
DK - Danimarca 9
ET - Etiopia 9
PE - Perù 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
EU - Europa 8
LV - Lettonia 8
PR - Porto Rico 8
TH - Thailandia 8
AL - Albania 7
GH - Ghana 7
GP - Guadalupe 7
PA - Panama 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
CG - Congo 6
DO - Repubblica Dominicana 6
KE - Kenya 6
KZ - Kazakistan 6
AM - Armenia 5
HU - Ungheria 5
JO - Giordania 5
LK - Sri Lanka 5
NO - Norvegia 5
OM - Oman 5
PS - Palestinian Territory 5
SI - Slovenia 5
UY - Uruguay 5
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
SN - Senegal 4
TW - Taiwan 4
Totale 31.046
Salva come PNG Salva come JPEG
Città #
Southend 2.219
Ashburn 1.791
Singapore 1.443
Jacksonville 1.283
Chandler 1.015
Moscow 909
San Jose 907
Woodbridge 823
Dallas 816
Ann Arbor 540
Hong Kong 476
Dublin 413
Houston 370
Beijing 311
The Dalles 308
Council Bluffs 293
Verona 247
Los Angeles 229
Wilmington 217
New York 194
Jinan 192
Buffalo 184
Lawrence 179
Princeton 178
Ho Chi Minh City 169
Nanjing 164
Shenyang 156
Hanoi 120
Santa Clara 107
Boardman 102
Hebei 100
Helsinki 99
São Paulo 91
Milan 89
Tianjin 79
Columbus 77
Sindelfingen 70
Zhengzhou 68
Munich 65
Rome 62
Changsha 58
Hangzhou 58
Philadelphia 58
Seattle 57
Haikou 55
Montreal 54
Nanchang 54
Taizhou 54
Orem 52
Jiaxing 49
Guangzhou 48
Dong Ket 45
Ningbo 45
Annandale 44
Atlanta 42
Fairfield 41
Falls Church 41
Tokyo 41
Frankfurt am Main 40
Toronto 39
Abuja 38
Brussels 38
Turku 37
Cambridge 35
Jakarta 34
Redondo Beach 33
Norwalk 32
Brooklyn 31
Warsaw 31
London 30
Taiyuan 30
Bologna 29
Chennai 28
Phoenix 28
Lancaster 27
Perth 27
Dearborn 26
Lanzhou 26
San Salvador 26
Seoul 26
Denver 25
Fuzhou 25
Haiphong 25
Chicago 23
Washington 23
Redwood City 22
Rio de Janeiro 22
Stockholm 22
Manchester 20
Redmond 20
San Francisco 20
Belo Horizonte 19
Naples 19
The Bronx 19
Johannesburg 18
North Bergen 18
Boston 17
Providence 17
Auburn Hills 16
Provo 16
Totale 19.148
Salva come PNG Salva come JPEG
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 492
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 306
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 305
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 305
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 284
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 270
Acute leukemia and pregnancy. Case report 261
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 258
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 257
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 255
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 255
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 254
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 254
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 253
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 250
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 249
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 247
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 244
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 242
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 240
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 239
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 239
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 237
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 235
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 234
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 233
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 232
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 229
Anemie iporigenerative ipercromiche e macrocitiche 227
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 224
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 224
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 222
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 222
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 220
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 219
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 219
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 218
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 217
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 216
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 214
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 213
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 213
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 213
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 212
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 210
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 210
An unusual case of acute leukaemia 209
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 207
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 206
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 205
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 204
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 202
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 202
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 201
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 201
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 201
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 200
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 198
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 197
Bone marrow transplantation monitoring by DNA analysis 195
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia 195
Leucemie 194
Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML 193
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 193
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 190
Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC. 190
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 190
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 188
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. 187
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 187
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 183
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 183
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience 183
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 182
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 182
Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis 182
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 181
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 181
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 180
Terminal transferase expression in relapsed acute myeloid leukaemia 179
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 176
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 176
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 174
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 173
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 173
BCR breakpoint subregions and blast crisis lineage in CML patients 173
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 172
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 171
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 171
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 169
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 169
Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the Third Workshop of the Molecular Biology/BMT Study Group 168
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 168
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 167
PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. 167
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 167
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients 166
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. 164
In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic bone marrow transplantation 164
Remission of severe antiphospholipid syndrome associated with non Hodgkin's B-cell lymphoma after combined treatment with Rituximab and chemotherapy 162
Totale 21.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.749
article - articoli 78.774
book - libri 0
conference - conferenze 15.700
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.275
Totale 195.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022789 0 0 0 0 83 45 31 92 58 39 134 307
2022/20232.962 227 279 290 538 309 701 47 154 311 25 62 19
2023/20241.428 69 141 130 175 156 198 59 103 17 72 195 113
2024/20253.736 264 228 118 618 241 146 186 181 573 194 290 697
2025/202610.200 751 602 858 1.480 2.365 661 1.061 553 790 665 199 215
2026/20272.648 208 276 542 1.415 207 0 0 0 0 0 0 0
Totale 31.289